ARTICLE | Management Tracks
Plus: Michael Lenardo to become CSO at Calico, and updates from Aveo and Dyadic
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
March 28, 2024 11:53 PM UTC
Antibody-drug conjugate company Mythic Therapeutics Inc. named George Eliades president and CEO. Eliades was SVP of corporate development and chief transformation officer at Jazz Pharmaceuticals plc (NASDAQ:JAZZ).
Michael Lenardo will become CSO of Calico Life Sciences LLC in August. Lenardo is co-director of the NIH’s National Institute of Allergy and Infectious Diseases Clinical Genomics Program…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/651930/george-eliades-at-the-helm-of-mythic